Navigation Links
Chlamydia IgG

ProductsChlamydia IgG
Company Inverness Medical Innovations
Item Chlamydia IgG
Features All kits include the following:
  • 12 x 8 well strips with breakaway wells
  • Controls and calibrators
  • TMB substrate
  • Stop solution
  • Directional insert
  • Sample diluent
  • Conjugate
  • Wash buffer
Description Our breadth of infectious disease ELISA products make us a leader in this field. With standard assay protocols for faster integration into the busy laboratory, our Infectious Disease ELISA products provide increased reliability and run-to-run consistency. Our Infectious Disease ELISA menu includes antibody detection assays for a wide range of serological assays including ToRCH, EBV, H. pylori and Lyme, among many others.
Info Inverness Medical Innovations
Customer Service: 800-257-9525
Web site: http://www.invernessmedical.com/

Related medicine products :

1. Chlamydia OIA
2. Clearview Chlamydia
3. Pathfinder® Chlamydia DFA
4. Pathfinder Chlamydia Microplate (EIA Microplate)
5. Pathfinder Chlamydia Culture Confirmation Test
6. MGB Alert Chlamydia pneumoniae ASR*
7. Chlamydia EIA
8. Chlamydia DFA Direct Specimen Collection Kit
9. Chlamydia DFA Direct Specimen Test
10. Chlamydia Antibody Panel, IgG by IFA
11. Chlamydia Group Antibody, Screen
Breaking Medicine News(10 mins):Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 2Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 3Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 2Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 2Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 4Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 5Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 6Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 7Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 8Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 9Health News:Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference 2